Replimune Group, Inc.

REPL Stock Healthcare Biotechnology
$10.86
-0.89 (-7.57%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-15.6%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Largest decline max drawdown, since Aug 2026
-32.0%

Own REPL?

See how REPL contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.